Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pål Suhrke

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancer Medicine|May 21, 2015
Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort studyPål Suhrke, Per-Henrik Zahl
The Breast Journal|September 26, 2012
Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and NorwayPål Suhrke, Jan Mæhlen, Per-Henrik Zahl
International Journal of Cancer|June 30, 2019
Quality-of-life effects of screening mammography in NorwayPer-Henrik Zahl, Mette Kalager, Pål Suhrke, et al.
BMJ (Clinical Research Ed.)|September 15, 2011
Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry dataPål Suhrke, Jan Mæhlen, Ellen Schlichting, et al.
Diagnostic Pathology|May 17, 2013
Expression of thyroid transcription factor-1 is associated with a basal-like phenotype in breast carcinomasTor A Klingen, Ying Chen, Pål Suhrke, et al.
BMC Clinical Pathology|September 2, 2017
Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in NorwaySveinung Wergeland Sørbye, Pål Suhrke, Berit Wallem Revå, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 21, 2023
Thymoma with pleural metastasesJanna Berg, Georgi Tonchev Tonev, John Olav Grimnes, et al.
Acta Oncologica (Stockholm, Sweden)|August 28, 2015
EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital TrustJanna Berg, Lars Fjellbirkeland, Pål Suhrke, et al.
Clinical and Experimental Medicine|January 19, 2024
Evaluation of NTRK expression and fusions in a large cohort of early-stage lung cancerAnne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, Pål Suhrke, et al.
Diagnostic Pathology|May 26, 2023
"Evaluation of ROS1 expression and rearrangements in a large cohort of early-stage lung cancer"Anne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, Pål Suhrke, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancer Medicine|May 21, 2015
Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort studyPål Suhrke, Per-Henrik Zahl
The Breast Journal|September 26, 2012
Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and NorwayPål Suhrke, Jan Mæhlen, Per-Henrik Zahl
International Journal of Cancer|June 30, 2019
Quality-of-life effects of screening mammography in NorwayPer-Henrik Zahl, Mette Kalager, Pål Suhrke, et al.
BMJ (Clinical Research Ed.)|September 15, 2011
Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry dataPål Suhrke, Jan Mæhlen, Ellen Schlichting, et al.
Diagnostic Pathology|May 17, 2013
Expression of thyroid transcription factor-1 is associated with a basal-like phenotype in breast carcinomasTor A Klingen, Ying Chen, Pål Suhrke, et al.
BMC Clinical Pathology|September 2, 2017
Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in NorwaySveinung Wergeland Sørbye, Pål Suhrke, Berit Wallem Revå, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 21, 2023
Thymoma with pleural metastasesJanna Berg, Georgi Tonchev Tonev, John Olav Grimnes, et al.
Acta Oncologica (Stockholm, Sweden)|August 28, 2015
EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital TrustJanna Berg, Lars Fjellbirkeland, Pål Suhrke, et al.
Clinical and Experimental Medicine|January 19, 2024
Evaluation of NTRK expression and fusions in a large cohort of early-stage lung cancerAnne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, Pål Suhrke, et al.
Diagnostic Pathology|May 26, 2023
"Evaluation of ROS1 expression and rearrangements in a large cohort of early-stage lung cancer"Anne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, Pål Suhrke, et al.
Pageof 2